Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $366.9 million.

  • Legend Biotech's Shares Outstanding (Weighted Average) rose 1.24% to $369.1 million in Q3 2025 from the same period last year, while for Mar 2022 it was $308.5 million, marking a year-over-year increase of 15.83%. This contributed to the annual value of $366.9 million for FY2024, which is 0.91% up from last year.
  • Latest data reveals that Legend Biotech reported Shares Outstanding (Weighted Average) of $366.9 million as of FY2024, which was up 0.91% from $363.6 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Shares Outstanding (Weighted Average) ranged from a high of $366.9 million in FY2024 and a low of $258.7 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $363.6 million (2023), whereas its average is $346.4 million.
  • Data for Legend Biotech's Shares Outstanding (Weighted Average) shows a peak YoY grew of 17.78% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Legend Biotech's Shares Outstanding (Weighted Average) stood at $258.7 million in 2020, then increased by 12.35% to $290.7 million in 2021, then grew by 6.21% to $308.7 million in 2022, then rose by 17.78% to $363.6 million in 2023, then rose by 0.91% to $366.9 million in 2024.